共 50 条
- [41] Concomitant, sequential, and 7-day triple therapy in first-line treatment of Helicobacter pylori infection in Korea: study protocol for a randomized controlled trialTrials, 18Hyuk LeeBeom Jin KimSang Gyun KimJin Il KimIl Ju ChoiYong Chan LeeJae G. KimJae J. Kim
- [42] Efficacy of 7-Day and 14-Day Bismuth-Containing Quadruple Therapy and 7-Day and 14-Day Moxifloxacin-Based Triple Therapy as Second-Line Eradication for Helicobacter pylori InfectionGUT AND LIVER, 2015, 9 (04) : 478 - 485Lee, Seong TaeLee, Dong HoLim, Ji HyunKim, NayoungPark, Young SooShin, Cheol MinJo, Hyun JinSong, In Sung
- [43] Seven-Day Vonoprazan-Based Triple Therapy as First-Line Helicobacter pylori Treatment in Comparison With Extended Sequential Therapy: A Randomized Controlled TrialHELICOBACTER, 2024, 29 (04)Chiu, Yu-TseLee, Fu-JenKuo, Chen-YaChen, Yu-TsungLin, Yang-ChaoLiang, Kai-ShunWu, Chun-YingLin, Ro-TingLin, Jaw-TownChang, Chi-Yang
- [44] SEVEN-DAY VONOPRAZAN-BASED TRIPLE THERAPY AS FIRST-LINE HELICOBACTER PYLORI TREATMENT IN COMPARISON WITH EXTENDED SEQUENTIAL THERAPY: A RANDOMIZED CONTROLLED TRIALGASTROENTEROLOGY, 2024, 166 (05) : S436 - S436Chiu, Yu-TseLee, Fu-JenKuo, Chen YaChen, Yu-TsungLin, Yang-ChaoLiang, Kai-ShunLin, Jaw-TownChang, Chi-Yang
- [45] Effect of the CYP2C19 polymorphism on the eradication rate of Helicobacter pylori infection by 7-day triple therapy with regular proton pump inhibitor dosageJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 (08) : 1287 - 1291Kang, Jung MookKim, NayoungLee, Dong HoPark, Young SooKim, Joo SungChang, In JinSong, In SungJung, Hyun Chae
- [46] High efficacy of 7-day and 14-day vonoprazan-based quadruple therapy for Helicobacter pylori eradication in areas with high clarithromycin resistance: A prospective randomized study (VQ-HP trial)JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 36 - 36Tungtrongchitr, N.Pornthisarn, B.Cholprasertsuk, S.Siramolpiwat, S.Bhanthumkomol, P.Nunanun, P.Issariyakulkarn, N.Eiamsitrakoon, T.Mahachai, V.Vilaichone, R. K.
- [47] EFFICACY OF NOVEL POTASSIUM-COMPETITIVE ACID BLOCKERS, VONOPRAZAN AND FEXUPRAZAN, VERSUS CONVENTIONAL PROTON PUMP INHIBITOR-BASED TRIPLE THERAPY FOR ERADICATION OF HELICOBACTER PYLORI, A RETROSPECTIVE COHORT STUDY IN A PHILIPPINE TERTIARY HOSPITALGASTROENTEROLOGY, 2024, 166 (05) : S441 - S442Gonzalez, Jose Maria I.Sollano, Jose Luis Matthias Z.Fores, Miguel EdgardoLozada, Angelo
- [48] Ten-Day Concomitant, 10-Day Sequential, and 7-Day Triple Therapy as First-Line Treatment for Helicobacter pylori Infection: A Nationwide Randomized Trial in KoreaGUT AND LIVER, 2019, 13 (05) : 531 - 540Kim, Beom JinLee, HyukLee, Yong ChanJeon, Seong WooKim, Gwang HaKim, Hyun-SooSung, Jae KyuLee, Dong HoKim, Heung UpPark, Moo InChoi, Il JuYoon, Soon ManKim, Sang WookBaik, Gwang HoLee, Ju YupKim, Jin IlKim, Sang GyunKim, JayounLee, JoongyupKim, Jae GyuKim, Jae J.
- [49] Efficacy of 7-day bismuth-based quadruple therapy versus 14-day moxifloxacinbased triple therapy for second-line treatment of Helicobacter Pylori infectionHELICOBACTER, 2016, 21 : 142 - 142Kim, S.Roh, J.Park, M.Park, S.Moon, W.Kim, J.Jung, K.Seol, S.